Coles Duncan R, Wilde Peter, Oberhoff Martin, Rogers Chris A, Karsch Karl R, Baumbach Andreas
Department of Cardiology, Bristol Royal Infirmary, Bristol BS2 8HW, UK.
Int J Cardiovasc Imaging. 2007 Oct;23(5):603-14. doi: 10.1007/s10554-006-9193-5. Epub 2006 Dec 13.
The aim of this prospective clinical study was to assess the accuracy and clinical relevance of multislice computed tomography coronary angiography (MSCTCA) in patients presenting with acute chest pain.
Multislice computed tomography coronary angiography has shown ability to detect accurately coronary artery disease (CAD) in selected elective patient groups.
One hundred and twenty patients presenting with acute chest pain (<24 h) underwent MSCTCA (Siemens Sensation 16) before a scheduled inpatient conventional coronary angiogram (CCA). Exclusion criteria included patients with STEMI, non-sinus rhythm, contraindication to beta blockers and renal impairment. Blinded visual assessment of MSCTCA to detect CAD was performed on an 11-segment model. The accuracy of MSCTCA was compared to CCA to detect significant stenoses (> or =50%).
One hundred and thirteen patients underwent both investigations. The prevalence of significant CAD was 74%. 1,243 native segments were assessed by MSCTCA. The overall ability of MSCTCA to detect the presence of > or =1 significant stenosis in all native segments had a sensitivity of 92% (95%CI 83-97%), specificity of 55% (95%CI 35-74%), positive predictive value of 86% (95%CI 76-93%) and negative predictive value of 70% (95%CI 47-87%). 22% of all segments (mostly distal) were non-analyzable. Coronary calcification was a major cause of false positivity.
In a prospective study of unselected patients presenting with acute chest pain, the diagnostic accuracy of 16-slice CT coronary angiography was moderate and less than reported from studies in elective patients. The clinical relevance of this technology to screen patients with acute chest pain is limited.
本前瞻性临床研究旨在评估多层螺旋计算机断层扫描冠状动脉造影(MSCTCA)对急性胸痛患者的准确性及临床相关性。
多层螺旋计算机断层扫描冠状动脉造影已显示出在特定择期患者群体中准确检测冠状动脉疾病(CAD)的能力。
120例急性胸痛(<24小时)患者在预定的住院常规冠状动脉造影(CCA)前接受了MSCTCA(西门子Sensation 16)检查。排除标准包括ST段抬高型心肌梗死(STEMI)患者、非窦性心律患者、β受体阻滞剂禁忌证患者及肾功能损害患者。在11段模型上对MSCTCA进行盲法视觉评估以检测CAD。将MSCTCA检测显著狭窄(≥50%)的准确性与CCA进行比较。
113例患者接受了两项检查。显著CAD的患病率为74%。MSCTCA评估了1243个天然节段。MSCTCA在所有天然节段中检测到≥1处显著狭窄的总体能力,敏感性为92%(95%可信区间83 - 97%),特异性为55%(95%可信区间35 - 74%),阳性预测值为86%(95%可信区间76 - 93%),阴性预测值为70%(95%可信区间47 - 87%)。所有节段的22%(大多为远端节段)无法分析。冠状动脉钙化是假阳性的主要原因。
在一项对未选择的急性胸痛患者的前瞻性研究中,16层CT冠状动脉造影的诊断准确性中等,低于择期患者研究报告的结果。该技术对急性胸痛患者进行筛查的临床相关性有限。